FDA Clearance Tracker · K210469
Insight Agile DRF
Last checked: Nov 19, 2026Latest source record: Jul 27, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Jul 27, 2021
Substantially Equivalent
Time to decision
161 days
Received Feb 16, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K210469
- Device name
- Insight Agile DRF
- Applicant
- Imaging Engineering, LLC
- Applicant location
- Cape Coral, FL
- Received
- Feb 16, 2021
- Decided
- Jul 27, 2021
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 892.1650
- Specialty
- Radiology & Imaging
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code JAA. The earliest in FDA's data is K761285, decided Dec 29, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K210469
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Imaging Engineering, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K251650 · Decided Sep 16, 2025 · 110 days after receipt
Device type: System, X-Ray, Fluoroscopic, Image-Intensified (JAA) · Radiology & Imaging
K200396 · Decided Mar 6, 2020 · 17 days after receipt
Device type: System, X-Ray, Fluoroscopic, Image-Intensified (JAA) · Radiology & Imaging
K191310 · Decided Jun 10, 2019 · 26 days after receipt
Device type: System, X-Ray, Fluoroscopic, Image-Intensified (JAA) · Radiology & Imaging
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.